202 related articles for article (PubMed ID: 11289162)
1. Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation.
Evron E; Umbricht CB; Korz D; Raman V; Loeb DM; Niranjan B; Buluwela L; Weitzman SA; Marks J; Sukumar S
Cancer Res; 2001 Mar; 61(6):2782-7. PubMed ID: 11289162
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D2 expression in familial and sporadic breast cancer.
Fischer H; Chen J; Skoog L; Lindblom A
Oncol Rep; 2002; 9(6):1157-61. PubMed ID: 12375011
[TBL] [Abstract][Full Text] [Related]
3. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
[TBL] [Abstract][Full Text] [Related]
4. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
5. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
6. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
[TBL] [Abstract][Full Text] [Related]
7. Biallelic inactivation of the thyroid hormone receptor beta1 gene in early stage breast cancer.
Li Z; Meng ZH; Chandrasekaran R; Kuo WL; Collins CC; Gray JW; Dairkee SH
Cancer Res; 2002 Apr; 62(7):1939-43. PubMed ID: 11929806
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer.
Nass SJ; Herman JG; Gabrielson E; Iversen PW; Parl FF; Davidson NE; Graff JR
Cancer Res; 2000 Aug; 60(16):4346-8. PubMed ID: 10969774
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation does not account for the frequent loss of the retinoic acid receptor beta2 in breast carcinoma.
Yang Q; Sakurai T; Yoshimura G; Mori I; Nakamura M; Nakamura Y; Suzuma T; Tamaki T; Umemura T; Kakudo K
Anticancer Res; 2001; 21(3B):1829-33. PubMed ID: 11497266
[TBL] [Abstract][Full Text] [Related]
11. Promoter methylation of cyclin D2 gene in gastric carcinoma.
Oshimo Y; Nakayama H; Ito R; Kitadai Y; Yoshida K; Chayama K; Yasui W
Int J Oncol; 2003 Dec; 23(6):1663-70. PubMed ID: 14612939
[TBL] [Abstract][Full Text] [Related]
12. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S
Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207
[TBL] [Abstract][Full Text] [Related]
13. Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer.
Bagadi SA; Prasad CP; Srivastava A; Prashad R; Gupta SD; Ralhan R
Breast Cancer Res Treat; 2007 Sep; 104(3):277-86. PubMed ID: 17115114
[TBL] [Abstract][Full Text] [Related]
14. Relaxin-like factor (RLF) is differentially expressed in the normal and neoplastic human mammary gland.
Hombach-Klonisch S; Buchmann J; Sarun S; Fischer B; Klonisch T
Cancer; 2000 Dec; 89(11):2161-8. PubMed ID: 11147585
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
[TBL] [Abstract][Full Text] [Related]
16. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.
Zhao C; Lam EW; Sunters A; Enmark E; De Bella MT; Coombes RC; Gustafsson JA; Dahlman-Wright K
Oncogene; 2003 Oct; 22(48):7600-6. PubMed ID: 14576822
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.
Umbricht CB; Evron E; Gabrielson E; Ferguson A; Marks J; Sukumar S
Oncogene; 2001 Jun; 20(26):3348-53. PubMed ID: 11423985
[TBL] [Abstract][Full Text] [Related]
18. [Expression and Significance of BP1 Gene and Cyclin D1 Gene in Breast Cancer].
Song YC; Fu SD; Wen XP; Ma ZH; Dang CX
Ai Zheng; 2007 Jul; 26(7):709-14. PubMed ID: 17626745
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation of the THRB gene in tissue and plasma of breast cancer patients.
Ling Y; Xu X; Hao J; Ling X; Du X; Liu X; Zhao X
Cancer Genet Cytogenet; 2010 Jan; 196(2):140-5. PubMed ID: 20082849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
